to 17 hr does not seem to affect the phosphorylation level of the Mr 60,000 protein. Younger Alzheimer disease patients had more prominent changes in the elevation of the Mr 60,000 protein phosphorylation level than older patients, although in the control patient, age did not affect the phosphorylation level of the Mr 60,000 protein. We conclude that in the brain cytosol of Alzheimer disease there may be an abnormality in either the degree of Mr 60,000 protein phosphorylation or in the Mr 60,000 protein concentration.
Alzheimer disease brings dementia and slow death to >5% of the adult population over the age of 64 yr. There is no clinically reliable diagnostic test for this disease, because clear anatomical and biochemical abnormalities are found only in brain tissue. Despite the accumulating anatomical and biochemical information, the primary abnormality in Alzheimer disease is not known. It is conceivable that the deficit is associated with atrophy of rather specific neurons (1) (2) (3) (4) . Furthermore, specific neurotransmitter receptors have been reported to be reduced in brains from Alzheimer disease patients (5) (6) (7) (8) (9) . This loss of receptors is probably associated with degeneration of specific types of neurons. Neurotransmitters for these receptors are associated either with neuritic plaques (10) (11) (12) or with neuronal tangles (13) . Thus, an obvious and critical question is why cholinergic and other neurons die in the brain of individuals with Alzheimer disease. No biochemical abnormality has been demonstrated to have a causal role in the neuronal degeneration.
The formation of neurofibrillary tangles is one of the major pathologic characteristics of neurons found in the brain of Alzheimer disease patients. It has been shown in tissue sections that perikarya of neurons that bear these tangles contain a phosphorylated form of neurofilament; in contrast, phosphorylated neurofilaments in normal brains are restricted to axons (14) . Thus, it is reasonable to suggest that in Alzheimer disease the lesion involves an imbalance of specific kinases responsible for phosphorylation of cytoskeletal elements, including neurofilaments. However, there has been no biochemical study of protein kinases in the brain of Alzheimer disease patients except in a very preliminary form (15, 16 (19) but also phosphoprotein phosphatases (20) (21) (22) (23) (24) . This homogenate was centrifuged 8 min at 2500 x g at 20C to pellet the nucleus and the majority of cytoskeletal components. The 2500 x g supernatant was then centrifuged 1 hr at 100,000 x g at 20C to separate membrane-rich fractions (100,000 x g pellet) from cytosol. Pellets were reconstituted to the original volume with the homogenization buffer, aliquoted, frozen in an ethanol/dry ice bath, and stored at -70'C until used for the phosphorylation reaction.
Phosphorylation and NaDodSO4/Polyacrylamide Gel Electrophoresis. Ten microliters of each fraction in the homogenization buffer containing 6.3 ,g total protein was mixed with 15 ,ul of reaction mixture containing 50 mM Tris'HCl, pH 7.6 (all concentrations are for final 25-,ul volume), 10 mM MgSO4, 10 ,g of protein kinase A inhibitor per ml (Sigma), 5 mM 2-mercaptoethanol, 10 ,uM ATP [y32P]ATP (1 ,uCi per *To whom reprint requests should be addressed.
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tube; 1 Ci = 37 GBq) (ICN), and 0.2 mM EDTA. The mixture underwent reaction for 12 min at 30'C. The reaction was stopped by addition of 6.3 /.l of a buffer containing 40% (vol/vol) glycerol, 25% 2-mercaptoethanol, 12% NaDodSO4, 0.31 M Tris HCl (pH 6.8), 25 mM EDTA, and 0.1% bromophenol blue. The samples were then subjected to 6.5-12.5% polyacrylamide gel (1-mm thick) electrophoresis with a 2-cm stacking gel (25) at a current of 20 mA per gel. The electrophoresis was stopped when the dye front reached 1 cm from the gel edge. Gels were fixed 1 hr in 10% acetic acid containing 15% isopropyl alcohol, stained 1 hr with 0.2% Coomassie brilliant blue in 10% acetic acid and 40% isopropyl alcohol, and destained in 10% acetic acid and 15% isopropyl alcohol. The destained gel was rinsed 1 hr with water, dried, and exposed -10 hr to Kodak X-Omat RP film with a Hi-Plus intensifying screen (DuPont) at -70'C. Protein concentrations were determined by the method ofLowry et al. (26) Controls. Before studying kinases or kinase substrates by using NaDodSO4/polyacrylamide gels, we must be sure that the NaDodSO4-soluble proteins shown on this one-dimensional gel are not detectably different in Alzheimer disease from those in controls. By studying Coomassie brilliant blue-stained protein patterns in NaDodSO4/polyacrylamide gels of membrane or cytosol fractions, we could not detect any consistent differences between brains from Alzheimer disease and control individuals (Fig. 1) . This is consistent with the results reported by other investigators (27, 28 protein comprises 4.1% ± 1.1% (SD) (n = 7) oftotal cytosolic phosphorylation, whereas in Alzheimer disease it represents 10.3% ± 3.4% (n = 8) (Fig. 2) . The difference is significant (P < 0.002). Phosphorylation of this protein does not seem to be cAMP, Ca2+/calmodulin, or lipid dependent. In the current study, the phosphorylation reaction mixture routinely included the cAMP-dependent protein kinase inhibitor protein. Elimination of this inhibitor with the concomitant addition of cAMP stimulated the phosphorylation of a number of proteins with molecular weights smaller than 50,000, leaving the Mr 60,000 protein phosphorylation unaffected. Previously, we detected Ca2+/calmodulin-dependent phosphorylation of Mr 65,000 protein and phorbol ester/ phosphatidylserine-dependent phosphorylation of Mr 86,000 (17) . Using the same conditions, we did not see any effect ofkinase activators on the Mr 60,000 protein phosphorylation in either control or test samples.
Before concluding altered phosphorylation of a Mr 60,000 protein in brains from Alzheimer disease patients, we need to consider two factors that may confound results obtained with postmortem brains. These two factors are age and postmortem times of brains. Postmortem time for control brains in this report was 7.2 ± 5.5 hr (n = 6; postmortem time for one case could not be obtained) and 7.6 ± 6.6 hr for test brains. Age for control brains was 78 ± 7 yr (n = 7) and 73 ± 6 yr (n = 8) for Alzheimer disease brains. As shown in Fig. 3 , the proportion of Mr 60,000 protein phosphorylation was not significantly correlated to the postmortem time. We do not know the postmortem time for one case. This may affect the statistics, because very long postmortem intervals may affect the degree of phosphorylation. Eliminating this case from the statistics, however, does not change our conclusion of increased Mr 60,000 protein phosphorylation in the Alzheimer group (4.3% ± 1.1% in control group vs. 10.2% ± 3.4% in Alzheimer disease patients; P < 0.002). Fig. 4 shows that younger patients demonstrate a more marked increase in the Mr 60,000 protein phosphorylation (r = -0.83; P < 0.01), although no age-dependent change in the Mr 60,000 protein phosphorylation was observed among the control group. It is of interest to note that younger patients have been reported to have more severe Alzheimer disease pathology, such as the loss of nerve cells, a reduction in nucleolar volume, and an increase in the frequency of neuritic plaques and neurofibrillary tangles, than older patients (29, 30 60,000 protein in the cytosol of patients with Alzheimer disease is enhanced as compared to that in controls.
What could be the molecular explanation for this increased level of Mr 60,000 protein phosphorylation in Alzheimer disease? The simplest explanation would be either increased levels of the Mr 60,000 protein kinase or of the Mr 60,000 protein itself. As is clear from studying Fig. 1 
